Sign inGet started

Dyrness Albert D.

Insider CIK 1664801 · SONN Director · ONS Director · PURR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PURR Hyperliquid Strategies Inc A Award2026-02-092026-02-1140,789— $041,671SEC↗
SONN Sonnet BioTherapeutics Hol D To issuer2025-12-022025-12-034,537— $00SEC↗
PURR Hyperliquid Strategies Inc J Other2025-12-022025-12-23882— $0882SEC↗
SONN Sonnet BioTherapeutics Hol A Award2023-12-112024-12-05373— $0537SEC↗
SONN Sonnet BioTherapeutics Hol A Award2023-07-112025-07-154,000— $04,537SEC↗
SONN Sonnet BioTherapeutics Hol P Buy2023-05-302023-05-3123,255$0.47 $10.9K28,962SEC↗
SONN Sonnet BioTherapeutics Hol A Award2022-12-142022-12-223,770— $030,893SEC↗
SONN Sonnet BioTherapeutics Hol A Award2021-12-152022-04-0814,152— $027,123SEC↗
SONN Sonnet BioTherapeutics Hol A Award2020-07-022020-07-028,005— $012,971SEC↗
SONN Sonnet BioTherapeutics Hol P Buy2020-06-112020-06-122,409$4.01 $9.7K4,966SEC↗
SONN Sonnet BioTherapeutics Hol A Award deriv2020-04-012020-04-031,279— $01,279SEC↗
SONN Sonnet BioTherapeutics Hol A Award2020-04-012020-04-032,557— $02,557SEC↗
ONS Oncobiologics, Inc. A Award deriv2017-10-262017-10-3015,000— $015,000SEC↗
ONS Oncobiologics, Inc. P Buy deriv2016-12-222016-12-2711,500— $011,500SEC↗